Biogen publishes Alzheimer’s drug data in low-ranking journal
The disease-modifying therapy, which was granted accelerated approval in the US last year, is currently under consideration by the TGA.
Tag: Dementia
Simple memory test correlates with brain plaque: study
The test is useful in research but may also guide clinicians on progression of a patient's cognitive deficits, a neurolo…
Pandemic distresses patients with dementia and their carers, survey finds
Lockdowns and disrupted routines have increased mental illness, researchers say.
Antipsychotics linked to increased mortality risk for patients with dementia
Pre-existing comorbidities also raise risk, but the effect of the drugs is independent of this, researchers say.
Dementia patients cared for by their own GPs have risk of delirium cut by 35%: study
Patients are also less likely to be hospitalised and are prescribed fewer medications.
Probe into death of patient on new Alzheimer’s drug
Meanwhile the sponsor has released further favourable clinical trial data.
Subclinical thyroid dysfunction ‘not linked’ to cognitive decline
Researchers say screening with the aim of reducing dementia risk is unwarranted.
‘No link’ between statins and dementia in over-65s
The analysis of results from ASPREE cofirms earlier studies, expert comentator says.
Why has it taken 20 years to approve the new Alzheimer’s drug?
Two weeks ago a new drug to treat Alzheimer’s disease was given accelerated approval by the US Food and Drug Administration. The drug is called aducanumab, commercially…
Is the ‘breakthrough’ Alzheimer’s drug approved by the FDA too good to be true?
A promising agent to tackle dementia has been filed for approval in Australia, but another trial is pending.
